National Medical Research Center for Cardiology, Moscow (Russian Federation)
Follow
Contributor content
Presentation
Sacubitril/valsartan improves heart failure functional class, left ventricular systolic and diastolic function and neurohumoral status in patients with anthracycline-induced cardiomyopathy